Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells. 1990

M Haneda, and R Kikkawa, and T Arimura, and K Ebata, and M Togawa, and S Maeda, and T Sawada, and N Horide, and Y Shigeta
Third Department of Medicine, Shiga University of Medical Science, Japan.

Although activation of polyol pathway has been proposed as one of the etiologic factors of diabetic complications, precise mechanism of the effect of polyol accumulation is still unclear. In order to test the hypothesis that there is an association of polyol pathway with myo-inositol metabolism, we measured myo-inositol content in cultured rat glomerular mesangial cells. By exposing the cells to high concentrations of glucose, intracellular myo-inositol content was reduced from 12.39 +/- 0.64 nmol/mg protein at 0 mmol/L glucose to 6.54 +/- 0.38 nmol/mg protein at 27.5 mmol/L glucose and 4.88 +/- 0.43 nmol/mg protein at 55 mmol/L glucose. This decrease of myo-inositol content was partially prevented by co-incubation with aldose reductase inhibitor, sorbinil. To examine further the mechanism of myo-inositol depletion, myo-inositol uptake by mesangial cells was studied. Major myo-inositol uptake process was sodium-dependent, saturable, and ouabain sensitive with Vmax of 171 pmol/mg protein/20 min and Km of 33 mumol/L. Sodium-dependent myo-inositol uptake was significantly inhibited by glucose in a dose-dependent manner only when glucose was present during uptake experiment, and kinetic analysis revealed the inhibition was competitive. Aldose reductase inhibition failed to prevent inhibitory effect of glucose on myo-inositol uptake. These data suggest that myo-inositol content of glomerular mesangial cells, which is reduced by high concentrations of glucose, is maintained by two processes: a glucose-sensitive but sorbitol-insensitive process, sodium-dependent myo-inositol uptake; and a sorbitol (aldose reductase) sensitive process, myo-Inositol depletion under high glucose condition may induce dysfunction of mesangial cells seen in diabetes.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007294 Inositol An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction. Myoinositol,Chiro-Inositol,Mesoinositol,Chiro Inositol
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010042 Ouabain A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE. Acocantherin,G-Strophanthin,Acolongifloroside K,G Strophanthin
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D003571 Cytochalasin B A cytotoxic member of the CYTOCHALASINS. Phomin
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005920 Glomerular Mesangium The thin membranous structure supporting the adjoining glomerular capillaries. It is composed of GLOMERULAR MESANGIAL CELLS and their EXTRACELLULAR MATRIX. Mesangium, Glomerular,Mesangial Extracellular Matrix,Extracellular Matrices, Mesangial,Extracellular Matrix, Mesangial,Glomerular Mesangiums,Matrices, Mesangial Extracellular,Matrix, Mesangial Extracellular,Mesangial Extracellular Matrices,Mesangiums, Glomerular

Related Publications

M Haneda, and R Kikkawa, and T Arimura, and K Ebata, and M Togawa, and S Maeda, and T Sawada, and N Horide, and Y Shigeta
January 1991, The American journal of physiology,
M Haneda, and R Kikkawa, and T Arimura, and K Ebata, and M Togawa, and S Maeda, and T Sawada, and N Horide, and Y Shigeta
February 1995, Kidney international,
M Haneda, and R Kikkawa, and T Arimura, and K Ebata, and M Togawa, and S Maeda, and T Sawada, and N Horide, and Y Shigeta
September 1994, The American journal of physiology,
M Haneda, and R Kikkawa, and T Arimura, and K Ebata, and M Togawa, and S Maeda, and T Sawada, and N Horide, and Y Shigeta
May 2009, Molecular and cellular biochemistry,
M Haneda, and R Kikkawa, and T Arimura, and K Ebata, and M Togawa, and S Maeda, and T Sawada, and N Horide, and Y Shigeta
December 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
M Haneda, and R Kikkawa, and T Arimura, and K Ebata, and M Togawa, and S Maeda, and T Sawada, and N Horide, and Y Shigeta
May 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
M Haneda, and R Kikkawa, and T Arimura, and K Ebata, and M Togawa, and S Maeda, and T Sawada, and N Horide, and Y Shigeta
March 1993, Kidney international,
M Haneda, and R Kikkawa, and T Arimura, and K Ebata, and M Togawa, and S Maeda, and T Sawada, and N Horide, and Y Shigeta
August 1997, Journal of the American Society of Nephrology : JASN,
M Haneda, and R Kikkawa, and T Arimura, and K Ebata, and M Togawa, and S Maeda, and T Sawada, and N Horide, and Y Shigeta
December 1992, Investigative ophthalmology & visual science,
M Haneda, and R Kikkawa, and T Arimura, and K Ebata, and M Togawa, and S Maeda, and T Sawada, and N Horide, and Y Shigeta
January 1993, Diabetic medicine : a journal of the British Diabetic Association,
Copied contents to your clipboard!